GE HealthCare Receives FDA Clearance for Diagnostic Imaging Viewer
The zero-footprint diagnostic viewer is designed to give radiologists browser-based access to imaging studies and visualization tools within the Genesis Radiology Workspace.
The zero-footprint diagnostic viewer is designed to give radiologists browser-based access to imaging studies and visualization tools within the Genesis Radiology Workspace.
The floor-mounted digital X-ray system automates in-room workflows and repetitive tasks to help improve throughput and reduce the technologist learning curve.
Recently cleared by the FDA, the tool leverages deep learning to reduce artifacts in cone-beam computed tomography imaging.
The zero-footprint diagnostic viewer is designed to give radiologists browser-based access to imaging studies and visualization tools within the Genesis Radiology Workspace.
GE HealthCare has partnered with Blackford to integrate AI-enabled applications into True PACS and Centricity PACS.
Read MoreFDA Center for Devices and Radiological Health (CDRH) director Jeff Shuren, who started in 1998 and became director in 2009, announced his retirement. Michelle Tarver, PhD, MD, will serve as interim director. Shuren will assist in finding his replacement and remain as center director emeritus.
Read MoreSamsung signed a supply contract with Lunit, provider of AI-powered solutions for cancer diagnostics and therapeutics.
Read MoreAkumin, a provider of radiology and oncology services, has been hit by a ransomware attack, forcing them to temporarily suspend scheduling new patients, accessing patient data, and delaying most clinical and diagnostic operations
Read MorePhilips’ Spectral Angio CT suite aims to bring the company’s spectral CT imaging technology into an integrated hybrid angio CT suite.
Read MoreCMS Imaging signed an agreement with GE Healthcare to provide sales, service, and support for the company’s Edison True PACS solution.
Read More
A new study shows a great disparity of hospital radiology service rates, when comparing those from Medicare and commercial negotiated prices.